% alzhub.org library filter
% Source: https://alzhub.org/research?author=Schneider+LS&score_min=67
% 15 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{schneider2005-16234500,
  author  = {Schneider, L. S. and Dagerman, K. S. and Insel, P.},
  title   = {{Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials}},
  journal = {JAMA},
  year    = {2005},
  doi     = {10.1001/jama.294.15.1934},
  pmid    = {16234500},
  url     = {https://doi.org/10.1001/jama.294.15.1934}
}

@article{green2009-20009055,
  author  = {Green, R. C. and Schneider, L. S. and Amato, D. A. and Beelen, A. P. and Wilcock, G. and Swabb, E. A. and Zavitz, K. H. and {Tarenflurbil Phase 3 Study Group}},
  title   = {{Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial}},
  journal = {JAMA},
  year    = {2009},
  doi     = {10.1001/jama.2009.1866},
  pmid    = {20009055},
  url     = {https://doi.org/10.1001/jama.2009.1866}
}

@article{gauthier2016-27863809,
  author  = {Gauthier, S. and Feldman, H. H. and Schneider, L. S. and Wilcock, G. K. and Frisoni, G. B. and Hardlund, J. H. and Moebius, H. J. and others},
  title   = {{Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial}},
  journal = {Lancet (London, England)},
  year    = {2016},
  doi     = {10.1016/s0140-6736(16)31275-2},
  pmid    = {27863809},
  url     = {https://doi.org/10.1016/s0140-6736(16)31275-2}
}

@article{aisen2008-18854539,
  author  = {Aisen, P. S. and Schneider, L. S. and Sano, M. and Diaz-Arrastia, R. and van Dyck, C. H. and Weiner, M. F. and Bottiglieri, T. and Jin, S. and others},
  title   = {{High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial}},
  journal = {JAMA},
  year    = {2008},
  doi     = {10.1001/jama.300.15.1774},
  pmid    = {18854539},
  url     = {https://doi.org/10.1001/jama.300.15.1774}
}

@article{kavirajan2007-17689146,
  author  = {Kavirajan, H. and Schneider, L. S.},
  title   = {{Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials}},
  journal = {The Lancet. Neurology},
  year    = {2007},
  doi     = {10.1016/s1474-4422(07)70195-3},
  pmid    = {17689146},
  url     = {https://doi.org/10.1016/s1474-4422(07)70195-3}
}

@article{teri2000-11087767,
  author  = {Teri, L. and Logsdon, R. G. and Peskind, E. and Raskind, M. and Weiner, M. F. and Tractenberg, R. E. and Foster, N. L. and Schneider, L. S. and others},
  title   = {{Treatment of agitation in AD: a randomized, placebo-controlled clinical trial}},
  journal = {Neurology},
  year    = {2000},
  doi     = {10.1212/wnl.55.9.1271},
  pmid    = {11087767},
  url     = {https://doi.org/10.1212/wnl.55.9.1271}
}

@article{rajji2025-40133524,
  author  = {Rajji, T. K. and Baksh, S. N. and Shade, D. M. and Ismail, Z. and Burhan, A. M. and Okhravi, H. R. and Padala, P. R. and Rosenberg, P. B. and Schneider, L. S. and Porsteinsson, A. P. and others},
  title   = {{Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial}},
  journal = {Nature Medicine},
  year    = {2025},
  doi     = {10.1038/s41591-025-03569-y},
  pmid    = {40133524},
  url     = {https://doi.org/10.1038/s41591-025-03569-y}
}

@article{schneider2006-16505124,
  author  = {Schneider, L. S. and Dagerman, K. and Insel, P. S.},
  title   = {{Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2006},
  doi     = {10.1097/01.jgp.0000200589.01396.6d},
  pmid    = {16505124},
  url     = {https://doi.org/10.1097/01.jgp.0000200589.01396.6d}
}

@article{rosenberg2010-20087081,
  author  = {Rosenberg, P. B. and Drye, L. T. and Martin, B. K. and Frangakis, C. and Mintzer, J. E. and Weintraub, D. and Porsteinsson, A. P. and Schneider, L. S. and others},
  title   = {{Sertraline for the treatment of depression in Alzheimer disease}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2010},
  doi     = {10.1097/jgp.0b013e3181c796eb},
  pmid    = {20087081},
  url     = {https://doi.org/10.1097/jgp.0b013e3181c796eb}
}

@article{tariot2011-21810649,
  author  = {Tariot, P. N. and Schneider, L. S. and Cummings, J. and Thomas, R. G. and Raman, R. and Jakimovich, L. J. and Loy, R. and Bartocci, B. and others},
  title   = {{Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease}},
  journal = {Archives of general psychiatry},
  year    = {2011},
  doi     = {10.1001/archgenpsychiatry.2011.72},
  pmid    = {21810649},
  url     = {https://doi.org/10.1001/archgenpsychiatry.2011.72}
}

@article{maust2015-25786075,
  author  = {Maust, D. T. and Kim, H. M. and Seyfried, L. S. and Chiang, C. and Kavanagh, J. and Schneider, L. S. and Kales, H. C.},
  title   = {{Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm}},
  journal = {JAMA psychiatry},
  year    = {2015},
  doi     = {10.1001/jamapsychiatry.2014.3018},
  pmid    = {25786075},
  url     = {https://doi.org/10.1001/jamapsychiatry.2014.3018}
}

@article{schneider2014-24605808,
  author  = {Schneider, L. S. and Mangialasche, F. and Andreasen, N. and Feldman, H. and Giacobini, E. and Jones, R. and Mantua, V. and Mecocci, P. and others},
  title   = {{Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014}},
  journal = {Journal of internal medicine},
  year    = {2014},
  doi     = {10.1111/joim.12191},
  pmid    = {24605808},
  url     = {https://doi.org/10.1111/joim.12191}
}

@article{schneider2019-31492718,
  author  = {Schneider, L. S. and Geffen, Y. and Rabinowitz, J. and Thomas, R. G. and Schmidt, R. and Ropele, S. and Weinstock, M. and {Ladostigil Study Group}},
  title   = {{Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial}},
  journal = {Neurology},
  year    = {2019},
  doi     = {10.1212/wnl.0000000000008239},
  pmid    = {31492718},
  url     = {https://doi.org/10.1212/wnl.0000000000008239}
}

@article{schneider2006-17035647,
  author  = {Schneider, L. S. and Tariot, P. N. and Dagerman, K. S. and Davis, S. M. and Hsiao, J. K. and Ismail, M. S. and Lebowitz, B. D. and Lyketsos, C. G. and others},
  title   = {{Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease}},
  journal = {The New England journal of medicine},
  year    = {2006},
  doi     = {10.1056/nejmoa061240},
  pmid    = {17035647},
  url     = {https://doi.org/10.1056/nejmoa061240}
}

@article{schneider2011-21482915,
  author  = {Schneider, L. S. and Dagerman, K. S. and Higgins, J. P. and McShane, R.},
  title   = {{Lack of evidence for the efficacy of memantine in mild Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2011},
  doi     = {10.1001/archneurol.2011.69},
  pmid    = {21482915},
  url     = {https://doi.org/10.1001/archneurol.2011.69}
}